Serum biomarkers confirming stable remission in inflammatory bowel disease

Serum biomarkers confirming stable remission in inflammatory bowel disease

Abstract Crohn's disease (CD) and ulcerative colitis (UC) have a chronic-remittent course. Optimal management of inflammatory bowel diseases (IBD) relies on early intervention, treat-to-target strategies and a tight disease control. However, it is challenging to assess the risk of relapses in i...

Full description

Bibliographic Details
Main Authors: Christoph Kessel, Miha Lavric, Toni Weinhage, Markus Brueckner, Sytze de Roock, Jan Däbritz, Jakob Weber, Sebastiaan J. Vastert, Dirk Foell
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-86251-w

Internet

https://doi.org/10.1038/s41598-021-86251-w

Similar Items